LSE - Delayed Quote GBp

Scancell Holdings plc (SCLP.L)

9.60 0.00 (0.00%)
As of April 23 at 4:25 PM GMT+1. Market Open.
Currency in GBP All numbers in thousands
Download
Breakdown
TTM
4/30/2023
4/30/2022
4/30/2021
4/30/2020
Total Revenue
--
5,271.00
--
--
--
Cost of Revenue
--
525.00
--
--
--
Gross Profit
--
4,746.00
--
--
--
Operating Expense
18,066.00
16,666.00
13,299.00
8,834.00
6,782.00
Operating Income
-18,066.00
-11,920.00
-13,299.00
-8,834.00
-6,782.00
Net Non Operating Interest Income Expense
-777.00
-931.00
-1,773.00
-7,971.00
14.00
Pretax Income
-11,956.00
-14,304.00
-6,272.00
-16,805.00
-6,768.00
Tax Provision
-2,428.00
-2,368.00
-1,703.00
-1,328.00
-1,262.00
Net Income Common Stockholders
-9,528.00
-11,936.00
-4,569.00
-15,477.00
-5,506.00
Diluted NI Available to Com Stockholders
-9,528.00
-11,936.00
-4,569.00
-15,477.00
-5,506.00
Basic EPS
-0.01
-0.01
-0.01
-0.02
-0.01
Diluted EPS
-0.01
-0.01
-0.01
-0.02
-0.01
Basic Average Shares
818,271.60
816,368.22
815,535.42
678,892.33
466,390.99
Diluted Average Shares
819,981.88
816,368.22
815,535.42
678,892.33
466,390.99
Total Operating Income as Reported
-18,066.00
-11,920.00
-13,299.00
-8,834.00
-6,782.00
Rent Expense Supplemental
123.00
--
--
--
123.00
Total Expenses
18,066.00
17,191.00
13,299.00
8,834.00
6,782.00
Net Income from Continuing & Discontinued Operation
-9,528.00
-11,936.00
-4,569.00
-15,477.00
-5,506.00
Normalized Income
-15,016.40
-10,723.54
-10,979.59
-15,477.00
-5,506.00
Interest Income
364.00
284.00
4.00
3.00
14.00
Interest Expense
1,141.00
1,215.00
1,777.00
1,651.00
--
Net Interest Income
-777.00
-931.00
-1,773.00
-7,971.00
14.00
EBIT
-10,815.00
-13,089.00
-4,495.00
-15,154.00
-6,768.00
EBITDA
-9,937.00
-12,187.00
-3,755.00
-14,905.00
-6,725.00
Reconciled Cost of Revenue
--
525.00
--
--
--
Reconciled Depreciation
878.00
902.00
740.00
249.00
43.00
Net Income from Continuing Operation Net Minority Interest
-9,528.00
-11,936.00
-4,569.00
-15,477.00
-5,506.00
Total Unusual Items Excluding Goodwill
6,887.00
-1,453.00
8,800.00
--
--
Total Unusual Items
6,887.00
-1,453.00
8,800.00
--
--
Normalized EBITDA
-16,824.00
-10,734.00
-12,555.00
-14,905.00
-6,725.00
Tax Rate for Calcs
0.00
0.00
0.00
0.00
0.00
Tax Effect of Unusual Items
1,398.60
-240.54
2,389.41
--
--
4/30/2020 - 2/12/2010

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

6YG.F Immunocore Holdings plc
53.00
-0.93%
 
NOVOBc.XC
 
BVXP.L Bioventix PLC
4,477.00
+0.04%
 
DEST.L Destiny Pharma plc
22.00
-4.35%
 
OXB.L Oxford Biomedica plc
220.00
+2.33%
 
FARON.HE Faron Pharmaceuticals Oy
1.5900
+2.98%
 
REDX.L Redx Pharma Plc
10.00
-2.44%
 
AVCT.L Avacta Group Plc
44.50
0.00%
 
SAR.L Sareum Holdings plc
35.45
+5.82%
 
ATXI Avenue Therapeutics, Inc.
0.1340
+3.00%